Caricamento...
Dasatinib-induced pleural effusion: Chylothorax, an option to consider
Dasatinib is a drug for treatment of oncogene fusion protein BCR-ABL-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant/intolerant to imatinib. Pleural effusion (PE) is a common adverse effect, and in this context, we present four cases seen...
Salvato in:
| Pubblicato in: | Ann Thorac Med |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070439/ https://ncbi.nlm.nih.gov/pubmed/27803756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1817-1737.191871 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|